Literature DB >> 27561360

Antimycobacterial Metabolites from Marine Invertebrates.

Georgios Daletos1, Elena Ancheeva1, Chaidir Chaidir2, Rainer Kalscheuer1, Peter Proksch3.   

Abstract

Marine organisms play an important role in natural product-based drug research due to accumulation of structurally unique and bioactive metabolites. The exploration of marine-derived compounds may significantly extend the scientific knowledge of potential scaffolds for antibiotic drug discovery. Development of novel antitubercular agents is especially significant as the emergence of drug-resistant Mycobacterium tuberculosis strains remains threateningly high. Marine invertebrates (i.e., sponges, corals, gorgonians) as a source of new chemical entities are the center of research for several scientific groups, and the wide spectrum of biological activities of marine-derived compounds encourages scientists to carry out investigations in the field of antibiotic research, including tuberculosis treatment. The present review covers published data on antitubercular natural products from marine invertebrates grouped according to their biogenetic origin. Studies on the structure-activity relationships of these important leads are highlighted as well.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Antimycobacterial activity; Cytotoxicity; Marine invertebrates; Mycobacterium tuberculosis; Natural products; Selectivity

Mesh:

Substances:

Year:  2016        PMID: 27561360     DOI: 10.1002/ardp.201600128

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  1 in total

1.  A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases.

Authors:  Miroslava Šudomová; Mohammad Ali Shariati; Javier Echeverría; Ioana Berindan-Neagoe; Seyed Mohammad Nabavi; Sherif T S Hassan
Journal:  Mar Drugs       Date:  2019-11-14       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.